Long-term administration of quarterly IV ibandronate is...

Osteoporosis International 2012 / 06 Vol. 23; Iss. 6

Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension

G. Bianchi, E. Czerwinski, A. Kenwright, A. Burdeska, R. R. Recker, D. Felsenberg
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
23
Language:
english
Pages:
10
DOI:
10.1007/s00198-011-1793-9
Date:
June, 2012
File:
PDF, 268 KB
english, 2012
Conversion to is in progress
Conversion to is failed